AI-generated summary
The authors report a multicenter randomized controlled trial of a sports-cap device with 650 nm laser diodes used on the scalp every other day for 17 weeks in women with androgenetic alopecia. They report a 51% increase in hair counts compared with sham-treated controls and describe the treatment as safe and effective, while noting that the results suggest a potentially significant role for this therapy.
- Who or what was studied
- Healthy females aged 18 to 60 with Fitzpatrick skin Types I to IV and Ludwig-Savin Baldness Scale I-2 to II-2 androgenetic alopecia
- Wavelengths
- 650 nm
- Limits stated in the abstract
- The abstract does not state the total number of participants, so the size of the trial and the certainty of the findings cannot be judged from it.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on ovid.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 650 nm
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Laser, Low-level laser therapy, Androgenetic alopecia, Photobiomodulation, Randomized controlled trial, Sham. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.